An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis; Psoriasis
- Focus Therapeutic Use
- 29 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 29 Jan 2018 Status changed from not yet recruiting to recruiting.